|Articles|May 14, 2008
Quintiles Appoints Oren Cohen to Senior Vice President, Clinical Research Strategies
Oren Cohen, MD, promoted to Quintiles' senior vice president of clinical research strategies
Advertisement
Research Triangle Park, NC-April 16, 2008-Quintiles Transnational (www.quintiles.com ) today announced the appointment of Oren Cohen, MD, as senior vice president, clinical research strategies.
Most recently, Cohen held the position of chief medical and scientific officer. In his new role, Cohen will be responsible for evaluating and implementing new clinical research strategies, part of the company's "shape the future" objective. He also will continue to serve as managing director of Quintiles public health and government services.
Cohen is also a consulting professor of medicine at Duke University School of Medicine. He earned a medical degree from Duke University and completed his residency at New York Hospital/Cornell University Medical Center and his fellowship in infectious diseases at the National Institutes of Health. He is board-certified in internal medicine and infectious diseases and has written more than 50 scientific articles and book chapters. He is a fellow of the Infectious Diseases Society of America and serves as a reviewer for several highly respected medical journals. He has won numerous awards for his professional achievements and has presented his work at dozens of conferences around the world.
Most recently, Cohen held the position of chief medical and scientific officer. In his new role, Cohen will be responsible for evaluating and implementing new clinical research strategies, part of the company's "shape the future" objective. He also will continue to serve as managing director of Quintiles public health and government services.
Cohen is also a consulting professor of medicine at Duke University School of Medicine. He earned a medical degree from Duke University and completed his residency at New York Hospital/Cornell University Medical Center and his fellowship in infectious diseases at the National Institutes of Health. He is board-certified in internal medicine and infectious diseases and has written more than 50 scientific articles and book chapters. He is a fellow of the Infectious Diseases Society of America and serves as a reviewer for several highly respected medical journals. He has won numerous awards for his professional achievements and has presented his work at dozens of conferences around the world.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement